rizatriptan

Known as: rizatriptan [Chemical/Ingredient], Rizatriptán, N,N-Dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine 
 
National Institutes of Health

Related topics

Related topics

12 relations
Angina Pectoris, VariantDrug AllergyRizatriptan Sulfaterizatriptan 5 MG Disintegrating Oral Tablet
(More)

Narrower (4)

MK 0462Rizatriptan benzoaterizatriptan 10 MG Disintegrating Oral Tabletrizatriptan 10 MG Oral Tablet

Broader (3)

Serotonin AgonistsTriazolesTryptamines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Rizatriptan reduces vestibular-induced motion sickness in migraineurs
A previous pilot study suggested that rizatriptan reduces motion sickness induced by complex vestibular stimulation. In this… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine.
OBJECTIVE To determine an effective and tolerable dose of a novel oral calcitonin gene-related peptide (CGRP) receptor antagonist… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2006
2006
A randomized trial of rizatriptan in migraine attacks in children.
OBJECTIVE To examine the efficacy of rizatriptan and the consistency of treatment response in migraine attacks of children and… (More)
Is this relevant?
2004
2004
Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine
BACKGROUND Rizatriptan is an effective and fast acting drug for the acute treatment of migraine. Some nonsteroidal anti… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.
BACKGROUND The triptans, selective serotonin 5-HT(1B/1D) agonists, are very effective acute migraine drugs with a well- developed… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2000
2000
Rizatriptan in the treatment of menstrual migraine.
OBJECTIVE To determine the efficacy of oral rizatriptan 10 mg and 5 mg for treating menstrually associated migraine attacks… (More)
Is this relevant?
1998
1998
Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group.
Rizatriptan is a potent, oral, 5-HT1B/1D agonist with more rapid absorption and higher bioavailability than oral sumatriptan. It… (More)
  • table 2
  • table 3
  • table 4
Is this relevant?
1998
1998
Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group.
Rizatriptan is a selective 5-HT1B/1D receptor agonist with rapid oral absorption and early onset of action in the acute treatment… (More)
Is this relevant?
1997
1997
Rizatriptan has central antinociceptive effects against durally evoked responses.
The 5-HT(1B/1D) receptor agonist rizatriptan constricts intracranial, extracerebral blood vessels, inhibits neurogenic… (More)
Is this relevant?
1996
1996
Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group.
BACKGROUND Rizatriptan (MK-462) is a new 5-hydroxytryptamine1D (serotonin1D; 5-HT1D) receptor agonist for the acute treatment of… (More)
Is this relevant?